Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rudolph Navari, MD, PhD, FACP
University of Alabama at Birmingham
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
566 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fhp Health Center-Guam
Tamuning, Guam
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Kingman Regional Medical Center
Kingman, Arizona, United States
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Tibor Rubin Va Medical Center
Long Beach, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Desert Regional Medical Center
Palm Springs, California, United States
- Epic Care Cyberknife Center
Walnut Creek, California, United States
- Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Boulder Community Foothills Hospital
Boulder, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers - Centennial
Centennial, Colorado, United States
- Cancer Center of Colorado at Sloan'S Lake
Denver, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Denver Health Medical Center
Denver, Colorado, United States
- National Jewish Health-Main Campus
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Rose
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- Scl Health Saint Joseph Hospital
Denver, Colorado, United States
- the Women'S Imaging Center
Denver, Colorado, United States
- Western Surgical Care
Denver, Colorado, United States
- Mountain Blue Cancer Care Center - Swedish
Englewood, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- National Jewish Health-Western Hematology Oncology
Golden, Colorado, United States
- Grand Valley Oncology
Grand Junction, Colorado, United States
- Saint Mary'S Hospital and Regional Medical Center
Grand Junction, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Nov 2018
- Primary completion
- 8 Nov 2021
- Completion
- 1 May 2023
- Last update posted
- 6 Apr 2025
- Registered enrollment
- 690
- Registry id
- NCT03578081
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.